Digital imaging firm Schick Technologies this month reported a big jump in revenues as the firm's products begin to hit the market. For the year (end-March), Schick posted revenues of $38.5 million, up 139% compared with $16.1 million the year before.
Digital imaging firm Schick Technologies this month reported a big jump in revenues as the firm's products begin to hit the market. For the year (end-March), Schick posted revenues of $38.5 million, up 139% compared with $16.1 million the year before. The company had net income for the year of $2.4 million, compared with a net loss of $352,000 in 1997. The 1998 figures include a one-time patent litigation settlement of $600,000.
Schick reported that sales of its accuDEXA bone densitometer are going well. In addition, the Long Island City, NY, company reported that it received 510(k) clearance from the Food and Drug Administration for an additional application for accuDEXA: use of the system to help physicians determine the risk of fracture. AccuDEXA received its initial 510(k) market clearance in December for assessing bone mineral density (SCAN 4/15/98).
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.